Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection

BACKGROUND: Patients living with HIV (PLHIV) are prone to invasive pneumococcal disease. The 13-valent conjugated pneumococcal vaccine (PCV13) is currently recommended for all PLHIV, followed in most guidelines by a 23-valent polysaccharide pneumococcal vaccine. Data are scarce concerning the immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Romaru, Juliette, Bahuaud, Mathilde, Lejeune, Gauthier, Hentzien, Maxime, Berger, Jean-Luc, Robbins, Ailsa, Lebrun, Delphine, N’Guyen, Yohan, Bani-Sadr, Firouzé, Batteux, Frédéric, Servettaz, Amélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721113/
https://www.ncbi.nlm.nih.gov/pubmed/34987514
http://dx.doi.org/10.3389/fimmu.2021.791147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721113/
https://www.ncbi.nlm.nih.gov/pubmed/34987514
http://dx.doi.org/10.3389/fimmu.2021.791147

Ejemplares similares